Dobrzyński J - Search Results

1

Prediction of stroke using an algorithm to estimate arterial stiffness.

Kostis JB, Lin CP, Dobrzynski JM, Kostis WJ, Ambrosio M, Cabrera J. Kostis JB, et al. Among authors: dobrzynski jm. Int J Cardiol Cardiovasc Risk Prev. 2021 Oct 28;11:200114. doi: 10.1016/j.ijcrp.2021.200114. eCollection 2021 Dec. Int J Cardiol Cardiovasc Risk Prev. 2021. PMID: 34806088 Free PMC article.

2

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT).

Vakil D, Zinonos S, Kostis JB, Dobrzynski JM, Cosgrove NM, Moreyra AE, Kostis WJ. Vakil D, et al. Among authors: dobrzynski jm. J Clin Hypertens (Greenwich). 2021 Jul;23(7):1335-1343. doi: 10.1111/jch.14296. Epub 2021 Jun 2. J Clin Hypertens (Greenwich). 2021. PMID: 34076333 Free PMC article. Clinical Trial.

3

Use of advanced statistical techniques to predict all-cause mortality in the Systolic Blood Pressure Intervention Trial.

Kostis WJ, Cabrera J, Lin CP, Kostis JB, Wellings J, Zinonos S, Dobrzynski JM, Blickstein D. Kostis WJ, et al. Among authors: dobrzynski jm. Int J Cardiol Hypertens. 2020 Sep 19;7:100053. doi: 10.1016/j.ijchy.2020.100053. eCollection 2020 Dec. Int J Cardiol Hypertens. 2020. PMID: 33447775 Free PMC article.

4

Limitations of Randomized Clinical Trials.

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. Am J Cardiol. 2020 Aug 15;129:109-115. doi: 10.1016/j.amjcard.2020.05.011. Epub 2020 May 16. Am J Cardiol. 2020. PMID: 32560898 Review.

5

Statins and Erectile Dysfunction.

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. World J Mens Health. 2019 Jan;37(1):1-3. doi: 10.5534/wjmh.180015. Epub 2018 May 11. World J Mens Health. 2019. PMID: 29756418 Free PMC article. No abstract available.

6

Statins and Erectile Function.

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. Can J Cardiol. 2018 Jun;34(6):813.e5. doi: 10.1016/j.cjca.2018.02.014. Epub 2018 Feb 17. Can J Cardiol. 2018. PMID: 29729881 No abstract available.

7

Effect of cholesterol lowering with statins or proprotein convertase subtilisin/kexin type 9 antibodies on cataracts: A meta-analysis.

Dobrzynski JM, Kostis JB, Sargsyan D, Zinonos S, Kostis WJ. Dobrzynski JM, et al. J Clin Lipidol. 2018 May-Jun;12(3):728-733. doi: 10.1016/j.jacl.2018.02.002. Epub 2018 Feb 8. J Clin Lipidol. 2018. PMID: 29501393

8

Prevention of Cataract by Statins.

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. Am J Cardiol. 2016 Apr 1;117(7):1196. doi: 10.1016/j.amjcard.2016.01.001. Epub 2016 Jan 12. Am J Cardiol. 2016. PMID: 26851145 No abstract available.

9

Statin Use and Risk of Cataract Response to Letter.

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. J Cardiovasc Pharmacol Ther. 2016 Mar;21(2):223. doi: 10.1177/1074248415591701. Epub 2015 Jun 17. J Cardiovasc Pharmacol Ther. 2016. PMID: 26085336 No abstract available.

10

Response to letter on "statins use and risk of cataracts: firm conclusions are still far off".

Kostis JB, Dobrzynski JM. Kostis JB, et al. Among authors: dobrzynski jm. J Cardiovasc Pharmacol Ther. 2015 May;20(3):346-7. doi: 10.1177/1074248414560967. J Cardiovasc Pharmacol Ther. 2015. PMID: 25877656 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results